...
首页> 外文期刊>Macromolecular Research >Effect of stromal cell derived factor-1 alpha release from heparin-coated Co-Cr stent substrate on the recruitment of endothelial progenitor cells
【24h】

Effect of stromal cell derived factor-1 alpha release from heparin-coated Co-Cr stent substrate on the recruitment of endothelial progenitor cells

机译:肝素涂覆的Co-Cr支架基质释放基质细胞衍生因子1α对内皮祖细胞募集的影响

获取原文
获取原文并翻译 | 示例

摘要

The restoration of a damaged endothelium might be a fascinating way to reduce significantly late-thrombosis and restenosis in the stent treatment. It has been recently reported that the recruitment of endothelial progenitor cells (EPCs), capable for repairing a damaged endothelium, can be important in the vascular stent application. Therefore, we focused on the hypothesis that stromal cell-derived factor-1 alpha (SDF-1 alpha) acts as a key chemokine for the mobilization and recruitment of EPCs to the damaged endothelium lesion. In this study, the effect of SDF-1 alpha released from a cobalt-chromium alloy (Co-Cr) plate, vascular stent material, was investigated on the recruitment of EPCs in vitro. Dopamine-conjugated heparin was synthesized to introduce heparin onto Co-Cr. Heparin-coated Co-Cr surfaces were examined by water contact angle and attenuated total reflectance-Fourier transform infrared (ATRFTIR) to prove successful coating of heparin. Finally, SDF-1 alpha was bound to the coated heparin derivative. Amounts of loaded and released SDF-1 alpha were measured by ELISA, and the recruited EPC by released SDF-1 alpha was evaluated using two different migration assays. The quantity of SDF-1 alpha bound to the heparin-modified surface increased in a concentration-dependent manner and SDF-1 alpha was released over 28 days. Transwell migration assay revealed that soluble SDF-1 alpha released from the heparin-coated Co-Cr induced significantly more EPC recruitment than bare Co-Cr and heparin-coated Co-Cr. More importantly, fibrin gel migration assay further demonstrated that EPCs evidently respond to heparin-based substrate with SDF-1 alpha and this type of behaviors was surprisingly found at as low level as less 1 ng/day of SDF-1 alpha. These results are strongly encouraging for further in vitro and in vivo studies.
机译:恢复受损的内皮可能是减少支架治疗中晚期血栓形成和再狭窄的一种引人入胜的方法。最近有报道说,能够修复受损内皮的内皮祖细胞(EPC)的募集在血管支架的应用中可能很重要。因此,我们集中于这一假设,即基质细胞衍生因子1α(SDF-1 alpha)是EPC动员和募集到受损内皮病变的关键趋化因子。在这项研究中,研究了从钴铬合金(Co-Cr)板(血管支架材料)释放的SDF-1α对EPC体外募集的影响。合成多巴胺缀合的肝素以将肝素引入Co-Cr。通过水接触角和衰减的全反射-傅立叶变换红外光谱(ATRFTIR)检查肝素涂层的Co-Cr表面,以证明肝素涂层成功。最后,将SDF-1α与包被的肝素衍生物结合。通过ELISA测量负载和释放的SDF-1α的量,并使用两种不同的迁移测定法评估通过释放的SDF-1α募集的EPC。与肝素修饰的表面结合的SDF-1 alpha数量以浓度依赖的方式增加,并且SDF-1 alpha在28天内释放。 Transwell迁移分析表明,与裸露的Co-Cr和肝素涂覆的Co-Cr相比,从涂覆有肝素的Co-Cr释放的可溶性SDF-1α诱导的EPC募集明显更多。更重要的是,纤维蛋白凝胶迁移试验进一步证明EPC对SDF-1α对基于肝素的底物有明显反应,并且令人惊讶地发现这种类型的行为的SDF-1α含量低至1 ng / day。这些结果对于进一步的体外和体内研究非常令人鼓舞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号